Why Shares of ImmunityBio Were Up on Wednesday
ImmunityBio Inc.
WKN: A2QQ2E / Name: ImmunityBio / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
4,05 €
1,12 %
Why Shares of ImmunityBio Were Up on Wednesday
Shares of ImmunityBio (NASDAQ: IBRX) were up 10% at 11:40 a.m. ET on Wednesday. The clinical-stage biotech company focuses on cell therapies and immunotherapy platforms, including vaccines and
| Discover the groundbreaking benefits of Prime Peptides Semaglutide, a game-changer in healing and immunity enhancement. Unleash your body's potential with this advanced peptide, accelerating recovery and promoting overall vitality. Dive into the world of Prime Peptides and experience the difference Semaglutide can make in your life.
Neueste Beiträge
MichealCarter in Verizon Stock Didn't Deserve the Battering It Just Took, Verizon Communications Inc.